Abstract
The aim of this study was to investigate the association of three polymorphisms of CD154 with risk of SLE in Chinese population. The study population comprised 770 Chinese individuals, including 350 SLE patients and 420 healthy controls. The gene polymorphism was measured using Snapshot SNP genotyping assays and confirmed by sequencing. Serum CD154 (sCD154) level was measured by ELISA. Compared with control group, sCD154 levels were significantly increased in case group (P < 0.001). The minor C allele of rs1126535 was associated with a significantly increased risk of SLE as compared to the major T allele (P < 0.001). Furthermore, an increased frequency of C-G-A haplotype was also detected in case group which associated with an increased risk of SLE (P = 0.009). Notably, patients carrying rs1126535CT/CC genotypes had a higher sCD154 level compared with that carrying rs1126535TT genotype (P < 0.05). Unfortunately, analyses on the association between rs1126535 and several clinical manifestations of SLE failed to find any significant results. In conclusion, these results indicated that CD154 gene polymorphisms may associate with the risk of SLE and may play regulation role in the expression of sCD154 in SLE patients.
Similar content being viewed by others
References
Aringer M et al (2016) Toward new criteria for systemic lupus erythematosus-a standpoint. Lupus 25(8):805–811
Wu M et al (2016) The Role of gammadelta T Cells in systemic lupus erythematosus. J Immunol Res 2016:2932531
Araujo JA et al (2016) Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus. Rev Bras Reumatol (Rio J) 56(1):28–36
Andrade D et al (2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol 67(4):977–987
Zhu X et al (2015) Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus. Int J Clin Exp Med 8(10):19223–19231
Abdallah E, Waked E, Abdelwahab MA (2016) Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 35(1):29–34
Al-Rayes H et al (2016) Apolipoprotein E Gene polymorphisms in saudi patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 9:81–87
Shahin RM et al (2016) Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus in Egyptian Patients. Immunol Invest 45(3):235–242
Senhaji N et al (2015) The contribution of CD40/CD40L axis in inflammatory bowel disease: an update. Front Immunol 6:529
Oxer DS et al (2011) PPARgamma expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus 20(6):575–587
Liu MF et al (2001) Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity 34(2):107–113
Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren’s syndrome. Transl Res 148(6):281–288
Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37(6–7):457–464
Xu H et al (2015) Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner. Cell Immunol 295(1):46–51
Willis R et al (2014) Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 32(2):162–167
Willis R et al (2012) Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21(8):830–835
Goules A et al (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26(3):165–171
Ciferska H et al (2007) The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol 26(5):723–728
Urquizu-Padilla M et al (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol 36(5):953–960
Chen JM et al (2015) The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet 16:121
Lee SH et al (2014) The Interaction Between Allelic Variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res 6(2):137–141
Teruel M et al (2012) Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther 14(3):R154
Chadha S et al (2005) Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 13(5):669–676
Citores MJ et al (2004) The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis 63(3):310–317
Wang N, Peng XB, Zeng K (2007) Effect of prolactin on CD40/CD154 expression on peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Nan Fang Yi Ke Da Xue Xue Bao 27(9):1382–1384
Rider V et al (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28(12):2644–2649
Li X et al (2006) Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus 15(12):852–857
Wang M et al (2009) Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet Disord 10:141
Wang M, Zhang W, Zhang Y (2009) Activation signal transduction by proline-rich tyrosine kinase 2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Hybridoma (Larchmt) 28(5):333–339
Peeva E et al (2006) Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice. J Immunol 177(3):1401–1405
Acknowledgements
This study was supported by National Natural Science Foundation of China (No. 81260234, No. 81560552).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Author Yan Lan has received research grants from National Natural Science Foundation of China (grant number 81260234). Author Ye-Sheng Wei has received research grants from National Natural Science Foundation of China (grant number 81560552). All the authors declare that they have no conflict of interest.
Funding
This study was funded by National Natural Science Foundation of China (grant number 81260234, 81560552).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Xiang, Y., Guo, J., Peng, YF. et al. Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population. Rheumatol Int 37, 1287–1294 (2017). https://doi.org/10.1007/s00296-017-3745-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3745-y